Biocryst Pharmaceuticals buy Royal Bank of Canada
Start price
30.01.26
/
50%
€5.59
Target price
30.01.27
€10.92
Performance (%)
38.52%
Price
17:07
€7.74
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals has seen massive gains of 38.52%. This prediction currently runs until 30.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -7.040% | -7.040% |
| iShares Core DAX® | -1.741% | 5.666% |
| iShares Nasdaq 100 | 2.815% | 11.547% |
| iShares Nikkei 225® | -0.109% | 9.654% |
| iShares S&P 500 | 0.966% | 7.240% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target lowered by analysts at Royal Bank Of Canada from $14.00 to $13.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.60
30.06.25
30.06.25
€11.09
30.06.26
30.06.26
1.79%
17:07
17:07
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€8.90
06.05.25
06.05.25
€11.51
06.05.26
06.05.26
-13.04%
17:07
17:07
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.91
11.04.25
11.04.25
€9.75
11.04.26
11.04.26
39.83%
12.04.26
12.04.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.79
25.02.25
25.02.25
€10.47
25.02.26
25.02.26
-19.06%
26.02.26
26.02.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.61
05.11.24
05.11.24
€9.16
05.11.25
05.11.25
-6.99%
06.11.25
06.11.25
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.95
25.09.23
25.09.23
€9.44
25.09.24
25.09.24
-2.42%
26.09.24
26.09.24